BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26081024)

  • 21. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
    Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
    Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism.
    Marketou ME; Kintsurashvili E; Androulakis NE; Kontaraki J; Alexandrakis MG; Gavras I; Vardas PE; Gavras H
    Int J Cardiol; 2013 Oct; 168(3):2561-6. PubMed ID: 23582690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation.
    Pavanetto M; Zarpellon A; Giacomini D; Galletti P; Quintavalla A; Cainelli G; Folda A; Scutari G; Deana R
    Platelets; 2007 Aug; 18(5):357-64. PubMed ID: 17654305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M
    Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of biological activity of phenolic fraction from roots of Alhagi maurorum with properties of commercial phenolic extracts and resveratrol.
    Olas B; Hamed AI; Oleszek W; Stochmal A
    Platelets; 2015; 26(8):788-94. PubMed ID: 25901460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
    Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
    Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free radical scavenging and skin penetration of troxerutin and vitamin derivatives.
    Kessler M; Ubeaud G; Walter T; Sturm F; Jung L
    J Dermatolog Treat; 2002 Sep; 13(3):133-41. PubMed ID: 12227877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid.
    Toliopoulos IK; Simos YV; Daskalou TA; Verginadis II; Evangelou AM; Karkabounas SC
    Indian J Exp Biol; 2011 Dec; 49(12):904-8. PubMed ID: 22403863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
    Dell'Agli M; Maschi O; Galli GV; Fagnani R; Dal Cero E; Caruso D; Bosisio E
    Br J Nutr; 2008 May; 99(5):945-51. PubMed ID: 17927845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sitagliptin: anti-platelet effect in diabetes and healthy volunteers.
    Gupta AK; Verma AK; Kailashiya J; Singh SK; Kumar N
    Platelets; 2012; 23(8):565-70. PubMed ID: 22950787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
    Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
    Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
    Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of blood platelet adhesion and secretion by different phenolics from Yucca schidigera Roezl. bark.
    Olas B; Wachowicz B; Stochmal A; Oleszek W
    Nutrition; 2005 Feb; 21(2):199-206. PubMed ID: 15723749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascorbyl Stearate Promotes Apoptosis Through Intrinsic Mitochondrial Pathway in HeLa Cancer Cells.
    Mane SD; Thoh M; Sharma D; Sandur SK; Naidu KA
    Anticancer Res; 2016 Dec; 36(12):6409-6417. PubMed ID: 27919962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol, a phenolic antioxidant with effects on blood platelet functions.
    Olas B; Wachowicz B
    Platelets; 2005 Aug; 16(5):251-60. PubMed ID: 16011975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.